Drug Database
Back to search

Belgium· BE-AMP-SAM486204-00

Numient 145 mg - 36.25 mg

A levodopa und decarboxylasehemmer product containing levodopa, registered in Belgium by Amneal Pharma Europe. The same ATC class is registered in 12 of our 19 countries.

ATC N04BA02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedNumient 145 mg - 36.25 mgATCN04BA02REGISTER NO.BE-AMP-SAM486204-00PACKS LISTED0CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about levodopaAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Levodopa und decarboxylasehemmer is registered in 12 of 19 countries.

Countries holding a registration under ATC N04BA02 (levodopa und decarboxylasehemmer), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose
Search levodopa und decarboxylasehemmer products by name

Levodopa und decarboxylasehemmer · ATC N04BA02

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Levodopa
Manufacturer
Amneal Pharma Europe
Country
Belgium (BE)
ATC code
N04BA02
ATC class
Levodopa und Decarboxylasehemmer
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

158 interactions on record for levodopa und decarboxylasehemmer.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check levodopa und decarboxylasehemmer against other medicinesHow interaction checks work

Levodopa und decarboxylasehemmer · interactions on record

158 records

  • 4 severe
  • 122 moderate
  • 14 minor

Most severe, free to view

  • ProcarbazineL01XB01severe
  • OzanimodL04AA38severe
  • OzanimodL04AE02severe
  • Methylthioninium chlorideV03AB17severe

18 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Levodopa und decarboxylasehemmer in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levodopa und decarboxylasehemmer products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • United Kingdom (Northern Ireland) · Inbrija
  • Iceland · Inbrija
  • Liechtenstein · Inbrija
  • Norway · Inbrija

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d9c5d34e-0362-4f11-afc0-e05d3174287b
GET /v1/drugs/d9c5d34e-0362-4f11-afc0-e05d3174287b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Modified-release capsule, hard",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Numient 145 mg - 36.25 mg",
  "name_fr": "Numient 145 mg - 36.25 mg",
  "name_nl": "Numient 145 mg - 36.25 mg",
  "amp_code": "SAM486204-00",
  "strengths": [
    "145.0000",
    "145.0000",
    "26.2500",
    "26.2500"
  ],
  "pack_count": 3,
  "substances": [
    "Levodopa",
    "Carbidopa Monohydrate",
    "Carbidopa"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Levodopa and Decarboxylase Inhibitor",
  "authorisation_numbers": [
    "EU/1/15/1044/005",
    "EU/1/15/1044/004",
    "EU/1/15/1044/006"
  ]
}
API referenceMCP serverPlans

See everything about levodopa und decarboxylasehemmer.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console